<DOC>
	<DOCNO>NCT01965405</DOCNO>
	<brief_summary>In propose study People Living HIV/AIDS ( PLWHA ) , use step care model call Sequential Multiple Assignment Randomized Trial ( SMART ) examine efficacy low- high-intensity smoking cessation treatment nicotine dependent PLWHA incorporate current standard care prize-based contingency management . Intervention administer community-based HIV integrate care clinic downtown Detroit , high prevalence rate HIV/AIDS smoking Michigan . Phase 1 last 4 week , involve brief intervention help participant stop smoking . For phase 2 , participant assign different study arm depend whether Responders ( reduce smoking ) Non-responders ( continue smoke ) . 1 . Phase 1 : We hypothesize brief high-magnitude prize contingency management result great reduction smoke standard care alone . 2 . Phase 2a : We hypothesize non-responders assign contingency management likely reduce smoke throughout treatment abstain smoke follow-up point . 3 . Phase 2b : We hypothesize responder assign monitor low-magnitude prize contingency management likely maintain reduced abstinent smoking status follow-up time-points .</brief_summary>
	<brief_title>Smoking Cessation People Living With HIV/AIDS</brief_title>
	<detailed_description>All research related activity take place Tolan Park Medical Building locate 3901 Chrysler Service Dr , Detroit , 48201 . Participants Phase 1 randomized one two brief intervention base standard care guideline ( SoC ) : A ) brief counsel bupropion ( SoC ) ; B ) SoC plus brief high-magnitude prize CM ( HM-CM ) . At end Phase 1 , participant classify responder non-responders basis smoking reduction/abstinence . All participant continue receive bupropion . Non-responders enter Phase 2a randomly assign : A ) continue counsel monitor support quit smoking ( MS ) ; B ) MS plus prize CM abstinence ( MS+CM ) . Phase 1 responder enter Phase 2b randomly assign : A ) additional treatment ( NAT ) ; B ) Continued monitor low intensity prize CM ( LI-CM ) . The primary dependent variable include cotinine carbon monoxide ( CO ) level , long duration abstinence cigarette . Seven-day point prevalence use assess outcome post-treatment , 6-month 12-month follow-up point . Participants pay $ 35 intake $ 25 follow-up interview , occur post-phase 1 , post-phase 2 , 6-months 12-months treatment initiation . Some assessment well treatment session record ensure data quality .</detailed_description>
	<mesh_term>Tobacco Use Disorder</mesh_term>
	<mesh_term>Bupropion</mesh_term>
	<criteria>1 . Age 18 year old 2 . Able read understand English 3 . Smoke 10 cigarettes/day 4 . Patient enrol HIV clinic HIV AIDS diagnosis 1 . Are actively suicidal uncontrolled manic psychotic symptom require immediate care 2 . Are recovery pathological gambling ( PG ) 3 . Have contraindication bupropion treatment ( e.g. , presence epilepsy seizure disorder , use monoamine oxidase inhibitor antidepressant , presence eat disorder low weight ) 4 . Are already participate smoke cessation intervention .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>HIV</keyword>
	<keyword>AIDS</keyword>
	<keyword>Nicotine Dependence</keyword>
	<keyword>Smoking</keyword>
	<keyword>Smoking cessation</keyword>
	<keyword>Contingency Management</keyword>
</DOC>